Aditya Birla Sun Life Pharma & Healthcare Fund Payout Inc Dist cum Cap Wdrl
Empty
1–7 yearsInvestment Horizon
HNI,MATarget Segments
Empty
Performance and Risk Analysis
Historical returns, volatility patterns, and how this fund has performed relative to its benchmark.
Risk Profile
Standard Deviation19.7%
Sharpe Ratio0.39
Beta1.00
Strategy Details
A closer look at the investment thesis, portfolio construction, and current holdings.
Portfolio Holdings Overview
SectoralAllocation
Geographic Allocation
Domestic100%
Top Stock Holdings
CompanySectorAllocation
Sun Pharmaceuticals Industries LtdServices12.08%
Cipla LtdServices7.69%
Apollo Hospitals Enterprise LtdServices7.18%
Abbott India LtdServices6.09%
Torrent Pharmaceuticals LtdServices5.47%
Lupin LtdServices4.72%
Fortis Healthcare LtdServices4.58%
Ajanta Pharma LtdServices3.99%
Ipca Laboratories LtdServices3.85%
Aurobindo Pharma LtdServices3.82%
Operational & Regulatory Details
What it costs to invest, transaction mechanics, and regulatory disclosures you should know.
Costs and Fees
Total Expense Ratio (TER)2.33%
Regulatory & Tax Information
INF209KB1O09
ISINDailyDealing Frequency
BSE Healthcare PRBenchmark
LTCG | >1Year 12.5%% on gain above 1.25 Lakh
STCG | <1Year 20%%
Tax Implications (India)